RecruitingPhase 4NCT06197295

Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity

Efficacy and Safety of Solifenacin Combined With Mirabegron Versus Solifenacin With Vaginal Estrogen Cream for the Treatment of Detrusor Overactivity

Sponsor

Mackay Memorial Hospital

Enrollment

200 participants

Start Date

Jun 16, 2022

Study Type

INTERVENTIONAL

Conditions

Effect of Drug Urinary Bladder, Overactive

Summary

To investigates the effects of combined pharmacotherapy with solifenacin and mirabegron versus solifenacin with vaginal estrogen cream in women with detrusor overactivity.

Eligibility

Sex: FEMALEMin Age: 40 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Combination pharmacotherapy and a drug called Solifenacin with vaginal estrogen cream for people with effect of drug and urinary bladder, overactive. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 40 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSolifenacin with vaginal estrogen cream

Solifenacin 5mg with vaginal conjugated equine estrogen (CEE) 0.625 mg

DRUGCombination pharmacotherapy

Solifenacin 5mg and Mirabegron 25mg

Locations(1)

Mackay Memorial Hospital

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06197295

Related Trials

Efficacy and Safety of Remimazolam Besylate for Sedation in Post-Non-Cardiac Surgery Patients Requiring Mechanical Ventilation

NCT065755301 location

Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity

Conditions

Summary

Eligibility

Plain Language Summary

Interventions

Locations(1)

Related Trials

Efficacy and Safety of Remimazolam Besylate for Sedation in Post-Non-Cardiac Surgery Patients Requiring Mechanical Ventilation

NXT Post-Market Clinical Follow-up

Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet

Ambulatory Long Length URodynamics Evaluation

Effects of Salbutamol in Athletes and Implications for Screening and Sports